Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > History Repeats

<< Previous

Bullboard Posts

Next >>

Comment by Journeytcon Nov 08, 2023 7:28pm

152 Views

Post# 35724948

RE:RE:RE:RE:RE:RE:RE:History Repeats

There's an important detail regarding.. going to the dumpster. Matt did a huge promote after they hired the chief med officer to put together the phase 3 breast cancer trial. A on partnership and phase 3 initiation. Matt carried this illusion for 8 months after resignation of the chief med officer. He squeezed the hell out of the ATMs knowing coarse had changed. He is a skunk. Not to be trusted.

<< Previous

Bullboard Posts

Next >>

B2Gold stock buckles under news of labour strike in Mali